-
-
Call more information
660-596-2224 -
Authors: Arnaud Vincent Vanlander, M.D. et al Published in The Journal of the American Society of Anesthesiologists 2 2015, Vol.122, 343-352. doi:10.1097/ALN.0000000000000484 Background: Propofol is a short-acting intravenous anesthetic agent. In rare conditions, a life-threatening complication known as propofol infusion syndrome can occur. The pathophysiologic mechanism is still unknown. Some studies suggested that propofol acts as uncoupling […]
Read MorePublished in The Journal of the American Society of Anesthesiologists 2 2015, Vol.122, 317-324. doi:10.1097/ALN.0000000000000489 Authors: Tyler R. Call, M.D et al Background: Several retrospective studies suggest that perioperative care and anesthetic management for cancer resection may influence cancer recurrence or patient survival. Various intraoperative techniques such as paravertebral blocks, decreased opioid use, immunomodulation, and perioperative antiinflammatory […]
Read MorePublished in The Journal of the American Society of Anesthesiologists 2 2015, Vol.122, 307-316. doi:10.1097/ALN.0000000000000482 Authors: Stefanie Blain-Moraes, Ph.D. et al Background: Recent studies of anesthetic-induced unconsciousness in humans have focused predominantly on the intravenous drug propofol and have identified anterior dominance of alpha rhythms and frontal phase–amplitude coupling patterns as neurophysiological markers. However, it is unclear […]
Read MorePublished in The Journal of the American Society of Anesthesiologists 2 2015, Vol.122, 294-306. doi:10.1097/ALN.0000000000000547 Authors: Michael Bailey, Ph.D. et al Background: The effect of urinary alkalinization in cardiac surgery patients at risk of acute kidney injury (AKI) is controversial and trial findings conflicting. Accordingly, the authors performed a prospectively planned individual patient data meta-analysis of the […]
Read MoreThe budget proposal calls for a permanent repeal of Medicare’s widely reviled sustainable growth rate funding formula for physicians, but also calls for about $400 billion in cuts, mostly to Medicare and Medicaid, over the next decade. The reaction from healthcare providers to the Obama Administration’s $4 trillion 2016 budget proposal has been mixed, but […]
Read More